Rivaroxaban versus enoxaparin/vitamin K antagonist therapy in patients with venous thromboembolism and renal impairment

BACKGROUND: Patients with renal impairment receiving classical anticoagulation for venous thromboembolism (VTE) are at increased risk of bleeding and possibly pulmonary embolism. We examined the efficacy and safety of oral rivaroxaban in patients with VTE with and without renal impairment. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Bauersachs, Rupert M, Lensing, Anthonie WA, Prins, Martin H, Kubitza, Dagmar, Pap, Ákos F, Decousus, Hervé, Beyer-Westendorf, Jan, Prandoni, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Original Basic Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4351845/
https://www.ncbi.nlm.nih.gov/pubmed/25750589
http://dx.doi.org/10.1186/1477-9560-12-25

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4351845/
https://www.ncbi.nlm.nih.gov/pubmed/25750589
http://dx.doi.org/10.1186/1477-9560-12-25

Ejemplares similares